Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
GBP 3M -
Notice Type:
Contract Notice
Published Date:
07 June 2019
Closing Date:
05 July 2019
Location(s):
UK UNITED KINGDOM
Description:
Framework Agreement for the Supply of Pralidoxime Chloride for Injection

This procurement exercise is intended to establish a Framework Agreement against which Public Health England would call-off their requirements for the stockpile of pralidoxime chloride for injection.

To put a Framework Agreement in place for the supply of pralidoxime chloride for injection, to place call-off orders as and when required during the life of the Framework Agreement.

The duration of the Framework Agreement is 2 years with an option to extend for up to an additional 2 years.

The awarding of lots is not appropriate to this procurement as the requirement is for a specific product.

Download full details as .pdf
The Buyer:
The Secretary of State for Health and Social Care acting as part of the Crown through the Department of Health and Social Care
CPV Code(s):
33600000 - Pharmaceutical products
33660000 - Medicinal products for the nervous system and sensory organs